|
C12ORF57 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.116000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.556700E-03 |
| Normal-vs-Stage2 |
6.179800E-01 |
| Normal-vs-Stage3 |
2.110200E-01 |
| Normal-vs-Stage4 |
5.584800E-03 |
| Stage1-vs-Stage2 |
2.002200E-01 |
| Stage1-vs-Stage3 |
2.436400E-01 |
| Stage1-vs-Stage4 |
5.470000E-01 |
| Stage2-vs-Stage3 |
6.386200E-01 |
| Stage2-vs-Stage4 |
1.302200E-01 |
| Stage3-vs-Stage4 |
1.442230E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.089600E-02 |
| Normal-vs-AfricanAmerican |
3.142800E-01 |
| Normal-vs-Asian |
7.567700E-02 |
| Caucasian-vs-AfricanAmerican |
6.049800E-01 |
| Caucasian-vs-Asian |
7.577400E-01 |
| AfricanAmerican-vs-Asian |
7.590400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.247600E-02 |
| Normal-vs-Female |
4.715800E-02 |
| Male-vs-Female |
6.107200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.300100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.674400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.104200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.726800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.336800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.921800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.023000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.731000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.466200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.289200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.048200E-01 |
| Classical-VS-Follicular |
7.217700E-03 |
| Classical-VS-Other |
6.150800E-01 |
| Classical-VS-Normal |
7.255100E-03 |
| Tall-VS-Follicular |
5.580200E-02 |
| Tall-VS-Other |
9.977400E-01 |
| Tall-VS-Normal |
2.121700E-02 |
| Follicular-VS-Other |
5.937500E-02 |
| Follicular-VS-Normal |
7.011000E-01 |
| Other-VS-Normal |
1.380750E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.044000E-01 |
| Normal-vs-N1 |
2.822000E-02 |
| N0-vs-N1 |
7.164400E-02 |
|
|
